1323. Efficacy and Safety of Telavancin Compared to Vancomycin for Cystic Fibrosis Pulmonary Exacerbation in Adults

BACKGROUND: Telavancin (TLV) is an advanced generation lipoglycopeptide with activity against methicillin-resistant Staphylococcus aureus (MRSA), but there are limited patient outcomes in the setting of cystic fibrosis pulmonary exacerbation (CFPE). The study objective was to compare the efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shorman, Mahmoud, wadi, ghassan, Veve, Michael P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644835/
http://dx.doi.org/10.1093/ofid/ofab466.1515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644835/
http://dx.doi.org/10.1093/ofid/ofab466.1515

Ejemplares similares